1. Home
  2. RILY vs BCYC Comparison

RILY vs BCYC Comparison

Compare RILY & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILY

B. Riley Financial Inc.

HOLD

Current Price

$8.18

Market Cap

349.8M

Sector

Finance

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.15

Market Cap

279.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RILY
BCYC
Founded
1973
2009
Country
United States
United Kingdom
Employees
1380
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.8M
279.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RILY
BCYC
Price
$8.18
$4.15
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
997.9K
635.2K
Earning Date
03-31-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$3.92
52 Week High
$11.24
$9.18

Technical Indicators

Market Signals
Indicator
RILY
BCYC
Relative Strength Index (RSI) 46.92 49.62
Support Level $8.17 $3.95
Resistance Level $9.46 $4.75
Average True Range (ATR) 0.63 0.18
MACD -0.15 0.03
Stochastic Oscillator 54.39 95.31

Price Performance

Historical Comparison
RILY
BCYC

About RILY B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: